{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:46:02Z","timestamp":1792010762570,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007179","name":"Advanced Centre for Treatment Research and Education in Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.leukres.2026.108339","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:51:58Z","timestamp":1791269518000},"page":"108339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Functional substitution of imatinib-inactivated canonical oncoprotein BCR::ABL1 by overexpressed PLAG1 results in BCR::ABL1-independent resistance in blast phase of chronic myeloid leukemia"],"prefix":"10.1016","volume":"171","author":[{"given":"Rahul","family":"Mojidra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5614-3505","authenticated-orcid":false,"given":"Shashi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Gardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhausaheb","family":"Bagal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khattry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Gokarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Punatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-2276","authenticated-orcid":false,"given":"Rukmini","family":"Govekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2026.108339_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2026.108339_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","article-title":"Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis","volume":"105","author":"Koschmieder","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108339_bib3","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014"},{"key":"10.1016\/j.leukres.2026.108339_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246141","article-title":"Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update","volume":"20","author":"Bavaro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.leukres.2026.108339_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","article-title":"How I treat CML blast crisis","volume":"120","author":"Hehlmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108339_bib6","doi-asserted-by":"crossref","unstructured":"Saglio, G. et al. Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study. 116, 3852-3861, doi:https:\/\/doi.org\/10.1002\/cncr.25123 (2010).","DOI":"10.1002\/cncr.25123"},{"key":"10.1016\/j.leukres.2026.108339_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2017.04.007","article-title":"Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors","volume":"31","author":"Patel","year":"2017","journal-title":"Hematol. \/Oncol. Clin. North. Am."},{"key":"10.1016\/j.leukres.2026.108339_bib8","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3892\/ol.2020.11650","article-title":"Mutations in the BCR-ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis","volume":"20","author":"Liu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.leukres.2026.108339_bib9","article-title":"Intrinsic cellular resistance to BCR::ABL1 inhibitors","author":"Cruz-Rodriguez","year":"2026","journal-title":"Haematologica 111 2244-2265"},{"key":"10.1016\/j.leukres.2026.108339_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12079-021-00647-x","article-title":"Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia","volume":"16","author":"Narasimhan","year":"2022","journal-title":"J. Cell. Commun. Signal."},{"key":"10.1016\/j.leukres.2026.108339_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12964-026-02893-1","article-title":"Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib \u2013 novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled","volume":"24","author":"Agrawal","year":"2026","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.leukres.2026.108339_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114870","article-title":"p38 MAPK-mediated suppression of Nrf2-MPC2 axis drives metabolic reprogramming which confers imatinib resistance in blast crisis phase of chronic myeloid leukemia","volume":"455","author":"Bhat","year":"2026","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.leukres.2026.108339_bib13","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.30.4.765","article-title":"PLAG1, the prototype of the PLAG gene family: Versatility in tumour development (Review)","author":"Van Dyck","year":"2007","journal-title":"Int. J. Oncol. 30 765-774"},{"key":"10.1016\/j.leukres.2026.108339_bib14","first-page":"390","article-title":"Diagnostic Utility of PLAG1 Immunohistochemical Determination in Salivary Gland Tumors","volume":"22","author":"Rotellini","year":"2014"},{"key":"10.1016\/j.leukres.2026.108339_bib15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2026.108339_bib16","first-page":"59","article-title":"Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia","volume":"7","author":"Mojidra","year":"2025","journal-title":"Adv. Biomark. Sci. Technol."},{"key":"10.1016\/j.leukres.2026.108339_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep36158","article-title":"Rawcopy: Improved copy number analysis with Affymetrix arrays","volume":"6","author":"Mayrhofer","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.leukres.2026.108339_bib18","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.1009843107","article-title":"Allele-specific copy number analysis of tumors","volume":"107","author":"Van Loo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2026.108339_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189334","article-title":"aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations","volume":"12","author":"Renault","year":"2017","journal-title":"PloS. One"},{"key":"10.1016\/j.leukres.2026.108339_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.leukres.2026.108339_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.leukres.2026.108339_bib22","first-page":"423","article-title":"Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data","volume":"28","author":"Boeva","year":"2012","journal-title":"Bioinforma. (Oxf. Engl. )"},{"key":"10.1016\/j.leukres.2026.108339_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","article-title":"Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data","volume":"26","author":"Favero","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.leukres.2026.108339_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San. Diego Calif. )"},{"key":"10.1016\/j.leukres.2026.108339_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.leukres.2026.108339_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.leukres.2026.108339_bib27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.leukres.2026.108339_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-13-S2-S11","article-title":"Fold change and p-value cutoffs significantly alter microarray interpretations","volume":"13","author":"Dalman","year":"2012","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.leukres.2026.108339_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13148-024-01790-z","article-title":"Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases","volume":"16","author":"Vandenhoeck","year":"2024","journal-title":"Clin. epigenetics"},{"key":"10.1016\/j.leukres.2026.108339_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nar\/gkr688","article-title":"miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades","volume":"40","author":"Friedl\u00e4nder","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2026.108339_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.leukres.2026.108339_bib32","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gkab297","article-title":"miRTargetLink 2.0-interactive miRNA target gene and target pathway networks","volume":"49","author":"Kern","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2026.108339_bib33","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.leukres.2026.108339_bib34","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.leukres.2026.108339_bib35","first-page":"1091","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinforma. (Oxf. Engl. )"},{"key":"10.1016\/j.leukres.2026.108339_bib36","doi-asserted-by":"crossref","first-page":"D184","DOI":"10.1093\/nar\/gkaf1209","article-title":"JASPAR 2026: expansion of transcription factor binding profiles and integration of deep learning models","volume":"54","author":"Ovek Baydar","year":"2026","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2026.108339_bib37","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1091\/mbc.e12-10-0776","article-title":"Targeted inactivation of \u03b21 integrin induces \u03b23 integrin switching, which drives breast cancer metastasis by TGF-\u03b2","volume":"24","author":"Parvani","year":"2013","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.leukres.2026.108339_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-4608(98)00120-4","article-title":"Chromosomal Aberrations During Progression of Chronic Myeloid Leukemia Identified by Cytogenetic and Molecular Cytogenetic Tools: Implication of 1q12\u201321","volume":"108","author":"Su","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2026.108339_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12185-011-0796-9","article-title":"Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate","volume":"93","author":"Nadarajan","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108339_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2026.108339_bib41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/17474086.2019.1657400","article-title":"Trisomy 8 in acute myeloid leukemia","volume":"12","author":"Hemsing","year":"2019","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.leukres.2026.108339_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.96","article-title":"Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia","volume":"6","author":"Wang","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2026.108339_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/his.13341","article-title":"PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities","volume":"72","author":"Katabi","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.leukres.2026.108339_bib44","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood-2004-09-3630","article-title":"Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11","volume":"105","author":"Landrette","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108339_bib45","doi-asserted-by":"crossref","first-page":"25276","DOI":"10.18632\/oncotarget.8252","article-title":"MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2026.108339_bib46","first-page":"1510","article-title":"The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities","volume":"62","author":"Hensen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2026.108339_bib47","article-title":"Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2026.108339_bib48","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood.V126.23.3583.3583","article-title":"PLAG1 and USF2 Regulate Primitive Hematopoietic Expression of Musashi-2","volume":"126","author":"Belew","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108339_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5732\/cjc.011.10327","article-title":"Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells","volume":"31","author":"Peng","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.leukres.2026.108339_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214335","article-title":"Integrating Single-Cell Transcriptome and Network Analysis to Characterize the Therapeutic Response of Chronic Myeloid Leukemia","volume":"23","author":"Ma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.leukres.2026.108339_bib51","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41375-020-01011-5","article-title":"RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses","volume":"35","author":"Adnan Awad","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2026.108339_bib52","first-page":"1714","article-title":"Transcriptome Analysis of Chronic Myelogenous Leukemia Cell Line with Imatinib Resistance]","volume":"29","author":"Han","year":"2021","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"10.1016\/j.leukres.2026.108339_bib53","doi-asserted-by":"crossref","first-page":"25534","DOI":"10.1074\/jbc.M115.656702","article-title":"Integrin \u03b13\u03b21 Binding to Fibronectin Is Dependent on the Ninth Type III Repeat","volume":"290","author":"Brown","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2026.108339_bib54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-2143(97)90192-X","article-title":"Pathophysiology of CML: Do defects in integrin function contribute to the premature circulation and massive expansion of the BCR\/ABL positive clone?","volume":"129","author":"Verfaillie","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.leukres.2026.108339_bib55","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/cancers12071910","article-title":"Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates","volume":"12","author":"Samar\u017eija","year":"2020","journal-title":"Cancers"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:10Z","timestamp":1792008070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"alternative-id":["S0145212626001839"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108339","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional substitution of imatinib-inactivated canonical oncoprotein BCR::ABL1 by overexpressed PLAG1 results in BCR::ABL1-independent resistance in blast phase of chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108339"}}